Table 4.
Concentrations of 13–197 in mouse and rat tissues after 5 mg/kg intravenous dose and 50 mg/kg oral dose (N=5, Mean ± SEM).
| Tissue | Time | IV-5mg/kg ng/g tissue |
Oral-50 mg/kg ng/g tissue |
|---|---|---|---|
| Mice | |||
| Liver | 8 h | 12262 ± 2601 | 209 ± 21 |
| 72 h | 1548 ± 143 | 3.0 ± 0.7 | |
| Lung | 8 h | 48217 ± 15521 | 61 ± 4.7 |
| 72 h | 4901 ± 1116 | 1.3 ± 0.9 | |
| Kidney | 8 h | 613 ± 45 | 113 ± 20 |
| 72 h | 346 ± 50 | 2.4 ± 0.8 | |
| Spleen | 8 h | 8859 ± 2718 | 30 ± 6.4 |
| 72 h | 1538 ± 96 | 1.9 ± 0.8 | |
| Heart | 8 h | 3205 ± 1033 | 69 ± 10 |
| 72 h | 404 ± 32 | 6.7 ± 2.6 | |
| Brain | 8 h | 67 ± 21 | 1.13 ± 0.16 |
| 72 h | 5.6 ± 1.1 | <LLOQ | |
| Rat | |||
| Liver | 72 h | 43 ± 25 | 7.0 ± 2.5 |
| Kidney | 72 h | 196 ± 108 | 20 ± 7.7 |
| Lung | 72 h | 52 ± 24 | 7.0 ± 2.0 |
| Spleen | 72 h | 39 ± 18 | 9.4 ± 3.7 |
| Heart | 72 h | 23 ± 11 | 4.4 ± 1.9 |
| Brain | 72 h | 93 ± 53 | 0.8 ± 0.2 |